2016
DOI: 10.1016/j.bbadis.2015.10.022
|View full text |Cite
|
Sign up to set email alerts
|

Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin

Abstract: Leptin administration within the subphysiological to physiological range diminishes atherosclerotic lesions. Leptin appears to mediate its antiatherogenic effects indirectly through reduction of hypercholesterolemia and liver steatosis, as well as upregulation of insulin-sensitizing and atheroprotective adiponectin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
26
0
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 39 publications
(29 citation statements)
references
References 40 publications
2
26
0
1
Order By: Relevance
“…MCP‐1 plays a fundamental role in monocyte recruitment and increased MCP‐1 expression is detected in atherosclerotic lesions of both humans and animals but not in normal arteries . In agreement with proatherogenic effects of IL‐6 and MCP‐1, leptin within the subphysiological to physiological range dose‐dependently decreases atherosclerotic lesion area in female leptin‐deficient LDLR −/− ; ob/ob mice in this study similar to recent findings from our group in male animals . These published findings and our present data are in agreement with the hypothesis that the anti‐atherogenic effects of subphysiological to physiological leptin doses are mediated in part by reduction of both pro‐inflammatory IL‐6 and MCP‐1.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…MCP‐1 plays a fundamental role in monocyte recruitment and increased MCP‐1 expression is detected in atherosclerotic lesions of both humans and animals but not in normal arteries . In agreement with proatherogenic effects of IL‐6 and MCP‐1, leptin within the subphysiological to physiological range dose‐dependently decreases atherosclerotic lesion area in female leptin‐deficient LDLR −/− ; ob/ob mice in this study similar to recent findings from our group in male animals . These published findings and our present data are in agreement with the hypothesis that the anti‐atherogenic effects of subphysiological to physiological leptin doses are mediated in part by reduction of both pro‐inflammatory IL‐6 and MCP‐1.…”
Section: Discussionsupporting
confidence: 93%
“…Similar to published data from our group in male animals [20], leptin dose-dependently decreased lesion size in the aortic root (Fig. 4A) in female LDLR −/− ;ob/ob mice as compared to saline with most pronounced effects observed at 3.0 mg/kg BW/day leptin.…”
Section: Leptin Dose-dependently Reduces Atherosclerotic Lesion Size supporting
confidence: 90%
“…Previous studies have shown lower adiponectin mRNA expression in leptin-deficient ob/ob and leptin receptor-deficient db/db mice 2931 , as well as in obese Zucker fa/fa rats lacking functional leptin receptors 32 , and that leptin significantly increases Adipoq expression in WAT 18, 23, 33, 34 and in the heart 35 . Interestingly, we found lower amounts of adiponectin protein in WAT of ob/ob mice consistent with other studies 30, 36, 37 , but leptin replacement failed to normalize its levels.…”
Section: Discussionmentioning
confidence: 95%
“…This reduction was associated to an increased circulating leptin level in HF-fed mice. While Ad and leptin were described as two independent factors which are dysregulated in MetS [48], recent studies found that leptin could induce Ad expression in differentiated human white preadipocytes [49], in ob/ob [50, 51] and in LDLR -/- mice [51]. Singh et al also suggested that leptin resistance may contribute to the reduced Ad expression in obese patients [49].…”
Section: Discussionmentioning
confidence: 99%